Induction therapy of leflunomide and cyclosporine allows for long-term xenograft survival under cyclosporine alone.
Lin
Y
Y
Transplantation Laboratory, University of Leuven, Belgium.
Sobis
H
H
Vandeputte
M
M
Waer
M
M
D000818:Animals; D006224:Cricetinae; D016572:Cyclosporine / Q000627:therapeutic use*; D004357:Drug Synergism; D006084:Graft Rejection / Q000473:pathology / Q000517:prevention & control; D006085:Graft Survival / Q000187:drug effects / Q000276:immunology*; D016027:Heart Transplantation / Q000276:immunology* / Q000473:pathology; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007555:Isoxazoles / Q000627:therapeutic use*; D000077339:Leflunomide; D051381:Rats; D013997:Time Factors; D014183:Transplantation, Heterologous / Q000276:immunology* / Q000473:pathology
D007166:Immunosuppressive Agents; D007555:Isoxazoles; D016572:Cyclosporine; D000077339:Leflunomide